Label Changes for:

Zemplar (paricalcitol) 2 mcg/mL and 5 mcg/mL injection

August 2009

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- August 2009

ADVERSE REACTIONS

Postmarketing Experience
  • angioedema (including laryngeal edema)
Hide
(web4)